1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Clinical trial NCT02333071 · COMPLETED
Trial details
- NCT number
- NCT02333071
- Sponsor
- Palatin Technologies, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-07-01
- Enrollment
- 723
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.